| INTRODUCTION ON INSULIN GRANULE AGEING, DYNAMICS AND RELEASE
A pancreatic islet β-cell has an average volume of 763 μm 3 and contains approximately 5 to 6 × 10 3 insulin secretory granules (SGs),
with each SG having a mean diameter of 243 AE 73 nm. 1 Glucosestimulated insulin secretion (GSIS) occurs in 2 phases. The first phase develops rapidly after stimulation and lasts for a few minutes followed by a second sustained phase that rises slowly and lasts for 1 to 2 hours until glycaemia returns to resting levels. 2, 3 Notably, the lack of the first phase and a reduction of the second phase of insulin secretion are characteristic features of type 2 diabetes. 4 The observation of 2 phases of insulin secretion led to early speculations of different insulin SG pools contributing to secretion at different time points of GSIS. A widely accepted model describes the pool of insulin SGs that are already docked to the plasma membrane (PM) as readily releasable pool (RRP) because those SGs are regarded to be immediately released during the first phase of GSIS, 5 while the second phase is comprised mostly of SGs of the reserve pool (RP), meaning SGs that are recruited from deeper in the cell. [6] [7] [8] [9] In this model, the RRP accounts for 1% to 5% and the RP for 95% to 99% of the SGs of the β-cell. Overall, only a small fraction of insulin SGs of mouse β-cells is secreted in the first and second phase of GSIS with reported values between 0.14%/min and 0.05%/min, respectively. 10 In this classic model, SGs have to be docked to the PM and primed for exocytosis in series of ATP-dependent steps. [11] [12] [13] The main steps prior to exocytosis include contact of the 2 membranes, merging of membranes and opening of the fusion pore. 14 These processes are mainly mediated by soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE) proteins. They form functional complexes in order to bring the vesicle membrane in close contact to the PM and thus foster fusion of the 2 membranes. 15 SNARE proteins are categorized into R-SNAREs, which are present on the vesicle membrane, and Q-SNAREs on the target membrane. [16] [17] [18] The SNARE proteins for exocytosis of β-cell SGs are the same ones responsible for synaptic vesicle fusion, 11, 19 that is, the Q-SNAREs syntaxin 1 and Notably, complexin I also plays a critical role in the control of insulin SG exocytosis, since its overexpression or silencing strongly impairs insulin secretion. 27 Classification of insulin SGs into distinct pools reflects the prevailing view on synaptic vesicle pools for regulated secretion of classical neurotransmitters at neuronal synapses. 28 Recently, this model has been challenged by data obtained in experiments with primary β-cells and total internal reflection microscopy (TIRFM). It has been shown that a pool of SGs does not need to be docked to the PM, but that those SGs coming from deeper in the cell can fuse with the PM without any apparent time delay. Because of that they are called restless newcomers. 29 The existence of SGs that do not have to be docked to the PM to be able to undergo exocytosis has implications on the activity of the SNARE-complex during the 2 phases of insulin release. Notably, β-cells of Syntaxin 1a knockout mice showed fewer docked SGs and no fusion in the first phase of GSIS, but fusion of restless newcomers during second phase.
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The existence of preferential release of newly synthesized proteins in various secretory cell types, mainly of neural origin, was demonstrated several decades ago. [32] [33] [34] [35] [36] [37] Utilizing radiolabelling techniques the same phenomenon could also be shown for the secretion of insulin by β-cells of isolated rat islets. [38] [39] [40] [41] In these experiments, just a small portion of [ 3 H]leucine labelled insulin that was older than 1 day was released compared to a much higher fraction of younger labelled insulin. The preferential release of "young" insulin has implications for understanding insulin SG turnover and should therefore be combined with the previously mentioned data on spatially segregated SG pools. [5] [6] [7] [8] Integration of features such as SG age, position in the cell and molecular signature can foster insights into β-cell function and give hints about which of the processes leading to the exocytosis of insulin SGs are altered in the diabetic state. To achieve this goal, special systems have to be applied to enable the labelling and imaging of age-distinct SG pools. Specifically, several methods for a fluorescent, age-dependent labelling of cargo proteins have been developed. The first approaches were based on shifts of the spectra of fluorescent proteins over time. [42] [43] [44] 
| INSULIN-SNAP AS A RELIABLE GRANULE AGE REPORTER
The SNAP-tag is based on the human O6-alkylguanine-DNA alkyltransferase (ATG), which is a suicidal enzyme taking part in DNA repair.
SNAP has a size of 22 kDa and is a modified version of ATG without its DNA-binding function but retaining the ability to covalently bind to benzylguanine-based substrates. [48] [49] [50] The broad range of commercially By that, all existing insulin-SNAP is labelled, but not visible (blocked). Depending on the desired SG age, the labelled SG pool can be imaged at various time points after the fluorescent labelling. The specific characteristics of the SNAP system allow for the analysis of the labelled SGs using different approaches including live-cell imaging, microscopy of fixed samples, fluorimetry 46 or immuno-isolation ( Figure 1 ). Recently, we developed a protocol for correlative light and electron microscopy (CLEM) enabling the evaluation of labelled and unlabelled SGs in the same sample. 51 By now, we successfully targeted insulin SGs of insulinoma cell lines and mice with the SNAP-tag. 46 In addition, we generated transgenic pig and zebrafish strains expressing the insulin-SNAP reporter (unpublished data), thereby taking advantage of the specific characteristics of these different model systems to investigate the biology of time-resolved insulin SG pools.
| DYNAMICS OF AGED INSULIN SECRETORY GRANULES
TIRFM is a valuable approach for the investigation of vesicle dynamics since it allows for the selective excitation of labelled objects close to the plasma membrane, thereby limiting out-of-focus signal and simultaneously minimizing photo-toxicity. Combined with high-speed acquisition (30 frames per second), automated detection and tracking with the MotionTracker software (http://motiontracking.mpi-cbg.de), it emerged to be an optimal tool to analyse the movement of agedefined insulin SGs in insulinoma cells. We found that the motility behaviour of "young" (3-5 hours old) and "old" (28-30 hours old) Ins-SNAP labelled SGs could be adequately distinguished using Bayesian probability theory 52 into 3 dynamic components: highly mobile, restricted and nearly immobile. 47 Most of the analysed SGs belonged either to the restricted or to the nearly immobile pool regardless of SG age. Surprisingly, old processively moving SGs appeared at first to be faster than young ones in standard culture conditions (11 mM glu- However, the numerous washing steps necessary for age-defined SNAP labelling cause most single β-cells to detach from the cover glass, making TIRFM very cumbersome. The dispersion of islet cells is also known to interfere with their secretory capacity and possibly SG turnover. 54, 55 Furthermore, TIRFM only allows the imaging of SGs found in very close proximity (<200 nm) to the plasma membrane.
Hence, an approach that is more likely to visualize all SG pools in primary β-cells is CLEM, which relies on the combination of fluorescence light microscopy (FLM) and electron microscopy (EM) on the same sample. 56 51 This surprising phenomenon is compatible with superior fixation methods such as high pressure freezing (HPF), which preserves the ultrastructure of the sample in a state close to nature. 59 Fixation of labelled SOFIA mouse islets by HPF, followed by freeze substitution and embedding in epoxy resin showed heterogeneity in insulin SG diameter with 2-day-old SGs being smaller than the overall SG population. In the future, this approach may also be exploited for 
| INSULIN SG AGEING IN HEALTH AND DISEASE
Maintaining the functionality of their proteins, so-called proteostasis, is a pivotal feature of healthy cells. 65 This process includes intracellular degradation (via proteasomes and lysosomes), and correct protein folding (chaperones). The role of endoplasmic reticulum (ER) stress in β-cells is controversial, 66 but several studies indicate a connection between type 2 diabetes and increased ER stress, 67, 68 which may finally result in β-cell apoptosis. Furthermore, the development of type 2 diabetes has been associated with the autophagy levels in β-cells 69 and autophagy has been demonstrated to be a major regulating pathway of β-cell homeostasis. 70 Accordingly, disruption of β-cell proteostasis is likely to contribute to the pathogenesis of this disease. 
| CONCLUSIONS AND OUTLOOK
Insulin SG turnover is a regulated process correlated with insulin secretion, degradation and SG interaction with the cytoskeleton.
However, the molecular mechanisms associated with SG ageing remain to be investigated. The different mobilities of age-distinct insulin SGs imply that SGs change their competence for motor FIGURE 3 The role of secretory granule (SG) ageing in insulin production and consumption in healthy (A) and diabetic (B) β-cells protein-mediated transport over time. Traditionally, it is assumed that SGs are carried to the cell periphery on microtubules while F-actin is forming a barrier under sub-stimulatory conditions. 72 Recently, however, it has been proposed that a dense microtubule network sequesters SGs in resting β-cells, with their access to the plasma membrane being facilitated instead upon glucose-induced depolymerization of microtubules. 73 Our own data indicate that cortical SGs strictly depend on microtubule-mediated transport for their motility and that their competence for it, as for secretion, decreases over time. 47 83 has been proposed to stabilize insulin SGs. 84 Hence, it might be interesting to investigate whether changes in ICA512 and its paralogue phogrin are connected with the preferential degradation of old SGs.
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The turnover of insulin SGs is a complex orchestrated process involving as key steps their biogenesis, maturation, exocytosis, degradation and interaction with the cytoskeleton. It is of vital relevance for β-cell
function, yet the molecular mechanisms regulating SG ageing remain to be uncovered.
The key for understanding the connection of SG age and behaviour lies most likely in modifications of the SG membrane but also its crosstalk with luminal components. Changes in the SG membrane may result from the pinching off of transmembrane proteins over time, for instance, upon partial fusion events followed by SG endocytosis, as previously described for zymogen granules. 85 To investigate the changes within the SG membrane with increasing age, age-defined SGs could be immuno-isolated from β-cells and subjected to proteomic or lipidomic analysis. This data could be helpful to investigate novel drug targets selectively acting on different SG pools, for instance, to amplify the recruitment of younger SGs or foster the "rejuvenation" of the older. The latter approach could be especially interesting since it might reduce the workload of β-cells compared to available insulin secretagogues used in the treatment of type 2 diabetes.
